Mayo Clinic research has identified a powerful new way to improve the prediction of a patient’s long-term cardiovascular disease risk by enhancing a routinely performed imaging test with artificial intelligence (AI). Heart disease develops over […]
When Ashley Perlow felt a sharp pain shoot across her chest and into both wrists, she didn’t think it could be a heart attack. She was 36, a new mom, and otherwise healthy. At the […]
A global clinical trial involving The Hospital for Sick Children (SickKids) has found that mavacamten—a heart medication previously approved for adults—can safely and effectively improve the flow of blood through compromised left ventricles in youth […]
The first randomized trial to test whether adding a small, temporary pump to allow the heart to rest and intentionally delaying percutaneous coronary intervention (PCI), also known as coronary angioplasty, for 30 minutes to reduce […]
Treatment management guided by the use of a noninvasive device to monitor fluid accumulation in the lungs substantially reduced hospitalizations and deaths among patients with heart failure with preserved ejection fraction (HFpEF), according to research […]
Atopic dermatitis (AD) during childhood is not associated with increases in markers of cardiovascular risk, according to a study published online March 24 in JAMA Network Open.This article was originally published on MedicalXpress.com
A study from researchers at The University of Texas at El Paso shows that just six weeks of boxing training can significantly reduce blood pressure and improve blood vessel function in young adults with elevated […]
Could showing someone a picture of plaque building up in their arteries be enough to save their life? That’s the question driving the latest research by the University of Tasmania’s Menzies Institute for Medical Research […]
For the first time since 2018, a clinical guideline from the American College of Cardiology and the American Heart Association for screening and managing blood cholesterol levels has been updated and jointly published in the […]
Mass General Brigham researchers found that the intensive cholesterol-lowering therapy evolocumab reduced the risk of a first major cardiovascular event in high-risk patients who did not have known atherosclerosis (the build-up of plaque inside artery […]
© 2025 SimplyWell.ca